The use of Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities.
作者信息
Franzese Elisena, Falco Stefano De, Laterza Maria Maddalena, Montella Liliana, Facchini Sergio, Liguori Carmela, Coppola Paola, Diessa Ylenia, Berretta Massimiliano, Pisconti Salvatore, Trama Francesco, Ferro Matteo, Crocetto Felice, Fasano Morena, Buonerba Carlo, Facchini Gaetano
机构信息
Medical Oncology Complex Unit, ASL Napoli 2 Nord 'Santa Maria delle Grazie' Hospital, Pozzuoli, Italy.
Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Napoli, Campania, Italy.
出版信息
Future Sci OA. 2021 Apr 7;7(6):FSO705. doi: 10.2144/fsoa-2021-0035.
Abstract
摘要
相似文献
1
The use of Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities.镓前列腺特异性膜抗原PET-CT在前列腺癌中的应用：诊断挑战与治疗机遇
Future Sci OA. 2021 Apr 7;7(6):FSO705. doi: 10.2144/fsoa-2021-0035.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用：系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
4
Ga-prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Prostate Cancer Imaging: A Narrative Literature Review.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描用于前列腺癌成像：一项叙述性文献综述
World J Nucl Med. 2017 Jan-Mar;16(1):3-7. doi: 10.4103/1450-1147.198237.
5
[Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer.[镓]PSMA PET/CT 可改善高危前列腺癌患者的初始分期和管理计划。
Mol Imaging Biol. 2019 Jun;21(3):574-581. doi: 10.1007/s11307-018-1278-8.
6
Clinical impact of Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach.镓标记前列腺特异性膜抗原（PSMA）正电子发射断层扫描/计算机断层扫描（PET/CT）在根治性治疗后前列腺特异性抗原升高的前列腺癌患者中的临床影响：多学科方法的初步分析
BJU Int. 2017 Aug;120(2):197-203. doi: 10.1111/bju.13739. Epub 2017 Jan 4.
7
Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描在晚期前列腺癌中的应用：现状与未来趋势
Prostate Int. 2017 Dec;5(4):125-129. doi: 10.1016/j.prnil.2017.02.003. Epub 2017 Feb 24.
8
The impact of [Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancer.[Ga]PSMA I&T PET/CT 对前列腺癌患者放疗计划的影响。
Strahlenther Onkol. 2018 Jul;194(7):646-654. doi: 10.1007/s00066-018-1291-5. Epub 2018 Mar 23.
9
Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.前列腺特异性膜抗原 (PSMA) PET 成像用冷试剂盒：Ga-Tris（羟基亚乙基二膦酸）-PSMA PET/CT 用于前列腺癌患者的 1 期研究。
J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6.
10
Gallium-68-prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.镓-68-前列腺特异性膜抗原（Ga-PSMA）正电子发射断层扫描（PET）/计算机断层扫描（CT）可预测中高危前列腺癌根治性前列腺切除术和淋巴结清扫术后的完全生化缓解。
BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7.
引用本文的文献
1
Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials.前列腺癌放疗中的局部剂量增强：计划研究与临床试验综述
Cancers (Basel). 2023 Oct 8;15(19):4888. doi: 10.3390/cancers15194888.
2
SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.用Tc-99m标记的HYNIC-FAPI-04进行单光子发射计算机断层显像以延长评估肿瘤纤维化的鉴别时间窗。
Pharmaceuticals (Basel). 2023 Mar 10;16(3):423. doi: 10.3390/ph16030423.
3
Integration between Novel Imaging Technologies and Modern Radiotherapy Techniques: How the Eye Drove the Chisel.新型成像技术与现代放射治疗技术的融合：眼睛如何驱动凿子。
Cancers (Basel). 2022 Oct 27;14(21):5277. doi: 10.3390/cancers14215277.
4
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow Up.前列腺特异性膜抗原正电子发射断层扫描-计算机断层扫描成像预测生化复发前列腺癌男性的治疗进展——一项对男性进行3年随访的前瞻性研究
Cancers (Basel). 2022 May 31;14(11):2717. doi: 10.3390/cancers14112717.
5
Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by Ga-PSMA PET/CT.通过镓-PSMA PET/CT检测评估前列腺癌患者生化复发的预测因素
Diagnostics (Basel). 2022 Jan 14;12(1):195. doi: 10.3390/diagnostics12010195.
本文引用的文献
1
Correlations between whole body volumetric parameters of Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients.镓-PSMA PET/CT 全身容积参数与去势抵抗性和去势敏感性前列腺癌患者生化-组织病理学参数的相关性。
Ann Nucl Med. 2021 May;35(5):540-548. doi: 10.1007/s12149-021-01594-8. Epub 2021 Feb 14.
2
[Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.[吕]Lu-PSMA-617 对比卡巴他赛用于转移性去势抵抗性前列腺癌（TheraP）患者：一项随机、开放标签、2 期试验。
Lancet. 2021 Feb 27;397(10276):797-804. doi: 10.1016/S0140-6736(21)00237-3. Epub 2021 Feb 11.
3
Evaluation of 68Ga-PSMA PET/CT with volumetric parameters for staging of prostate cancer patients.68Ga-PSMA PET/CT 容积参数评估前列腺癌患者分期。
Nucl Med Commun. 2021 May 1;42(5):503-509. doi: 10.1097/MNM.0000000000001370.
4
Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis.比较放射性示踪剂在复发性前列腺癌诊断中的性能：系统评价和网络荟萃分析。
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2978-2989. doi: 10.1007/s00259-021-05210-9. Epub 2021 Feb 6.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.阿帕鲁胺、恩扎卢胺和达罗他胺治疗非转移性去势抵抗性前列腺癌：系统评价和网络荟萃分析。
Int J Clin Oncol. 2020 Nov;25(11):1892-1900. doi: 10.1007/s10147-020-01777-9. Epub 2020 Sep 14.
7
Advanced Prostate Cancer: Treatment Advances and Future Directions.晚期前列腺癌：治疗进展与未来方向。
Trends Cancer. 2020 Aug;6(8):702-715. doi: 10.1016/j.trecan.2020.04.010. Epub 2020 Jun 10.
8
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.雄激素受体轴靶向治疗在转移性去势敏感前列腺癌患者中的疗效预测因素：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23.
9
Added value of Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous Tc bone scintigraphy.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描（Ga-PSMA PET/CT）在新诊断前列腺癌且既往行锝骨闪烁显像患者骨转移检测中的附加价值
EJNMMI Res. 2020 Apr 8;10(1):31. doi: 10.1186/s13550-020-00618-0.
10
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT（proPSMA）：一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
Zotero 插件